LUTRATE DEPOT

Main information

  • Trade name:
  • LUTRATE DEPOT Powder and solvent for prolonged-release suspension for injection 22,5MG
  • Dosage:
  • 22,5MG
  • Pharmaceutical form:
  • Powder and solvent for prolonged-release suspension for injection
  • Administration route:
  • Intramuscular use
  • Units in package:
  • 1+1X2ML ISP Vial
  • Prescription type:
  • with prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • LUTRATE DEPOT Powder and solvent for prolonged-release suspension for injection 22,5MG
    Czech Republic
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • LEUPRORELIN
  • Product summary:
  • LUTRATE DEPOT

Other information

Status

  • Source:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Authorization status:
  • B - medicinal product after change, may be placed on the market
  • Authorization number:
  • 44/ 301/15-C
  • Authorization date:
  • 30-09-2016
  • EAN code:
  • 8594044141970
  • Last update:
  • 17-01-2018